동물용 의약품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global veterinary pharmaceuticals market size is expected to reach USD 83.88 Billion in 2034 from USD 41.72 Billion in 2025, growing at a CAGR of 8.07 during 2026-2034.This market is expanding significantly due to the increasing focus on animal health and the rising demand for veterinary care. Veterinary pharmaceuticals include drugs used to treat and prevent diseases in animals, including livestock and companion animals. The growing pet population and increasing expenditure on animal healthcare are key factors driving market growth. Additionally, the expansion of livestock farming and the need for disease prevention are contributing to market expansion.

Growth drivers include advancements in pharmaceutical research and the development of innovative drugs and vaccines. The increasing awareness of zoonotic diseases and the need for preventive care are also supporting market growth. The expansion of veterinary services and the availability of advanced treatment options are contributing to increased adoption. Furthermore, government initiatives promoting animal health and welfare are supporting market growth.

Looking ahead, the veterinary pharmaceuticals market is expected to witness continuous innovation and development. Companies are likely to focus on developing targeted therapies and improving drug efficacy. The integration of biotechnology and advanced research techniques will further enhance product development. As the importance of animal health continues to grow, the demand for veterinary pharmaceuticals is anticipated to increase significantly.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Drugs (Anti-infective, Anti-inflammatory, Parasiticide)
• Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Others)
• Medicated Feed Additives (Amino Acids, Antibiotics and Antimicrobials)

By Indication

• Infectious Diseases
• Dermatologic Diseases
• Pain
• Orthopedic Diseases
• Behavioral Diseases
• Other

By Animal Type

• Production Animals/Livestock
• Companion Animals

By Route of Administration

• Oral Route
• Parenteral Route
• Topical Route

By Distribution Channels

• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies

COMPANIES PROFILED

• Zoetis Inc., Merck & Co. Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., Virbac SA, Dechra Pharmaceuticals PLC, Neogen Corporation, Phibro Animal Health Corporation, Vetoquinol, Norbrook, Hester Biosciences Limited, Ceva Sante Animale, Evonik Industries AG, Cargill Incorporated, Nutreco

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Drugs (Anti-infective, Anti-inflammatory, Parasiticide) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Vaccines (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Medicated Feed Additives (Amino Acids, Antibiotics and Antimicrobials) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Dermatologic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Orthopedic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Behavioral Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Animal Type
• 6.2. Production Animals/Livestock Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Route Of Administration
• 7.2. Oral Route Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Parenteral Route Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Topical Route Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY DISTRIBUTION CHANNELS 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Distribution Channels
• 8.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product Type
  • 9.2.2 By Indication
  • 9.2.3 By Animal Type
  • 9.2.4 By Route Of Administration
  • 9.2.5 By Distribution Channels
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product Type
  • 9.3.2 By Indication
  • 9.3.3 By Animal Type
  • 9.3.4 By Route Of Administration
  • 9.3.5 By Distribution Channels
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product Type
  • 9.4.2 By Indication
  • 9.4.3 By Animal Type
  • 9.4.4 By Route Of Administration
  • 9.4.5 By Distribution Channels
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product Type
  • 9.5.2 By Indication
  • 9.5.3 By Animal Type
  • 9.5.4 By Route Of Administration
  • 9.5.5 By Distribution Channels
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product Type
  • 9.6.2 By Indication
  • 9.6.3 By Animal Type
  • 9.6.4 By Route Of Administration
  • 9.6.5 By Distribution Channels
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY PHARMACEUTICALS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Zoetis Inc
  • 11.2.2 Merck & Co. Inc
  • 11.2.3 Boehringer Ingelheim International GmbH
  • 11.2.4 Elanco Animal Health Inc
  • 11.2.5 Virbac SA
  • 11.2.6 Dechra Pharmaceuticals PLC
  • 11.2.7 Neogen Corporation
  • 11.2.8 Phibro Animal Health Corporation
  • 11.2.9 Vetoquinol
  • 11.2.10 Norbrook
  • 11.2.11 Hester Biosciences Limited
  • 11.2.12 Ceva Sante Animale
  • 11.2.13 Evonik Industries AG
  • 11.2.14 Cargill Incorporated
  • 11.2.15 Nutreco